116 related articles for article (PubMed ID: 26139712)
1. Draft Genome Sequence of Pseudomonas aeruginosa Strain WS136, a Highly Cytotoxic ExoS-Positive Wound Isolate Recovered from Pyoderma Gangrenosum.
Arnold M; Wibberg D; Blom J; Schatschneider S; Winkler A; Kutter Y; Rückert C; Albersmeier A; Albaum S; Goesmann A; Zange S; Heesemann J; Pühler A; Hogardt M; Vorhölter FJ
Genome Announc; 2015 Jul; 3(4):. PubMed ID: 26139712
[TBL] [Abstract][Full Text] [Related]
2. The Frequency of Exotoxin A and Exoenzymes S and U Genes Among Clinical Isolates of Pseudomonas aeruginosa in Shiraz, Iran.
Yousefi-Avarvand A; Khashei R; Sedigh Ebrahim-Saraie H; Emami A; Zomorodian K; Motamedifar M
Int J Mol Cell Med; 2015; 4(3):167-73. PubMed ID: 26629485
[TBL] [Abstract][Full Text] [Related]
3. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
Finck-Barbançon V; Goranson J; Zhu L; Sawa T; Wiener-Kronish JP; Fleiszig SM; Wu C; Mende-Mueller L; Frank DW
Mol Microbiol; 1997 Aug; 25(3):547-57. PubMed ID: 9302017
[TBL] [Abstract][Full Text] [Related]
4. Draft Genome Sequence of Pseudomonas aeruginosa Strain WS394, a Multidrug-Resistant and Highly Cytotoxic Wound Isolate from Chronic Ulcus Cruris.
Vorhölter FJ; Arnold M; Wibberg D; Blom J; Winkler A; Viehoever P; Albersmeier A; Goesmann A; Zange S; Heesemann J; Pühler A; Hogardt M
Genome Announc; 2014 Dec; 2(6):. PubMed ID: 25523779
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.
Feltman H; Schulert G; Khan S; Jain M; Peterson L; Hauser AR
Microbiology (Reading); 2001 Oct; 147(Pt 10):2659-2669. PubMed ID: 11577145
[TBL] [Abstract][Full Text] [Related]
6. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
[TBL] [Abstract][Full Text] [Related]
7. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa.
Shi H; Chen Z; Kan J
Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of Pseudomonas aeruginosa related to bovine mastitis.
Park HR; Hong MK; Hwang SY; Park YK; Kwon KH; Yoon JW; Shin S; Kim JH; Park YH
Acta Vet Hung; 2014 Mar; 62(1):1-12. PubMed ID: 24334080
[TBL] [Abstract][Full Text] [Related]
9. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung.
Shaver CM; Hauser AR
Infect Immun; 2004 Dec; 72(12):6969-77. PubMed ID: 15557619
[TBL] [Abstract][Full Text] [Related]
10. An outbreak of fluoroquinolone-resistant Pseudomonas aeruginosa ST357 harboring the exoU gene.
Kainuma A; Momiyama K; Kimura T; Akiyama K; Inoue K; Naito Y; Kinoshita M; Shimizu M; Kato H; Shime N; Fujita N; Sawa T
J Infect Chemother; 2018 Aug; 24(8):615-622. PubMed ID: 29628388
[TBL] [Abstract][Full Text] [Related]
11. Molecular Detection of the Virulent ExoU Genotype of Pseudomonas aeruginosa Isolated from Infected Surgical Incisions.
Hassuna NA
Surg Infect (Larchmt); 2016 Oct; 17(5):610-4. PubMed ID: 27441791
[TBL] [Abstract][Full Text] [Related]
12. The Impact of ExoS on
Kroken AR; Chen CK; Evans DJ; Yahr TL; Fleiszig SMJ
mBio; 2018 May; 9(3):. PubMed ID: 29717012
[No Abstract] [Full Text] [Related]
13.
Foulkes DM; McLean K; Haneef AS; Fernig DG; Winstanley C; Berry N; Kaye SB
Microorganisms; 2019 Dec; 7(12):. PubMed ID: 31888268
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility pattern and distribution of exoU and exoS in clinical isolates of Pseudomonas aeruginosa at a Malaysian hospital.
Idris SN; Desa MN; Aziz MN; Taib NM
Southeast Asian J Trop Med Public Health; 2012 Jan; 43(1):116-23. PubMed ID: 23082561
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of cytotoxicity effectors in nosocomial Pseudomonas Aeruginosa strains].
Kuznetsova MV; Maksimova AV; Karpunina TI; Demakov VA
Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):9-14. PubMed ID: 25816507
[TBL] [Abstract][Full Text] [Related]
16. ExoU is a potent intracellular phospholipase.
Sato H; Frank DW
Mol Microbiol; 2004 Sep; 53(5):1279-90. PubMed ID: 15387809
[TBL] [Abstract][Full Text] [Related]
17. Draft genome sequence of KPC-2-producing Pseudomonas aeruginosa recovered from a bloodstream infection sample in Brazil.
de Oliveira Santos IC; Albano RM; Asensi MD; D'Alincourt Carvalho-Assef AP
J Glob Antimicrob Resist; 2018 Dec; 15():99-100. PubMed ID: 30172833
[TBL] [Abstract][Full Text] [Related]
18. Portable negative-pressure wound therapy for pyoderma gangrenosum: Report of two cases.
Yamaguchi Y; Yanagi T; Sato K; Yoshimoto N; Hirata Y; Ujiie I; Nishimura M; Natsuga K; Shiiya C; Tsukinaga I; Shimizu H
J Dermatol; 2018 Apr; 45(4):483-486. PubMed ID: 29235669
[TBL] [Abstract][Full Text] [Related]
19. Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media.
Park MH; Kim SY; Roh EY; Lee HS
Auris Nasus Larynx; 2017 Jun; 44(3):258-265. PubMed ID: 27461174
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin.
Barbieri JT
Int J Med Microbiol; 2000 Oct; 290(4-5):381-7. PubMed ID: 11111915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
